TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹63.92 | ₹56.47 | ₹48.94 | ₹36.79 | ₹22.96 |
What is the latest Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹63.92 |
| Mar2025 | ₹56.47 |
| Mar2024 | ₹48.94 |
| Mar2023 | ₹36.79 |
| Mar2022 | ₹22.96 |
How is Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹63.92 | 13.19 | |
| Mar2025 | ₹56.47 | 15.39 | |
| Mar2024 | ₹48.94 | 33.03 | |
| Mar2023 | ₹36.79 | 60.24 | |
| Mar2022 | ₹22.96 | - | |
Compare Earnings Per Share (EPS) of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹188,670.8 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,472.0 Cr | -2.4% | 1.2% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.9% |
10.1% |
44.6% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses